THE CURE - is a hardcore 3D shooter with surviving elements where you must survive in zombie apocalypse.
All Reviews:
1 user reviews - Need more user reviews to generate a score
Release Date:
23 Mar, 2023
Publisher:

Sign in to add this item to your wishlist, follow it, or mark it as ignored

Check out the entire Conglomerate 5 franchise on Steam

Buy THE CURE

HK$ 7.00
 

About This Game

THE CURE - is a hardcore 3D shooter with surviving elements where you must survive in zombie apocalypse. The main aim is surviving and exploring large locations, looking for different items such as keys, patrons, medical kits. There's one key on the maps which you must find and move to the next level. But be careful and cautious: you will meet various zombies that are hungry and waiting for your death. Save your ammos, explore locations, look for keys, kill zombies. The game will allow you to enjoy the zombie apocalypse atmosphere!

KEY Features:

- The simplest gameplay.
- Pixel graphics.
- Large and various locations.
- Incredible atmosphere.
- Cool impressions from the game.

System Requirements

    Minimum:
    • OS *: Windows XP\Vista\7\8
    • Processor: Intel Core i3
    • Memory: 1024 MB RAM
    • Graphics: 512MB
    • DirectX: Version 9.0
    • Storage: 100 MB available space
    • Additional Notes: Keyboard/Mouse
* Starting January 1st, 2024, the Steam Client will only support Windows 10 and later versions.

More from Conglomerate 5

What Curators Say

10 Curators have reviewed this product. Click here to see them.

Customer reviews

Review Type


Purchase Type


Language


Date Range
To view reviews within a date range, please click and drag a selection on a graph above or click on a specific bar.

Show graph



Playtime
Filter reviews by the user's playtime when the review was written:


No minimum to No maximum
Display As:
Show graph
 
Hide graph
 
Filters
Excluding Off-topic Review Activity
Playtime:
There are no more reviews that match the filters set above
Adjust the filters above to see other reviews
Loading reviews...